Equitymcapital Review

Updated: February 13, 2026
Equitymcapital
Views24

Fast Facts

Contact Info and Support

Traffic information

CategoryMetricsMeaning
RatingsGlobal Rank-
Country Code-
Country Rank-
Category Rank-
Engagement metricsVisits0
Bounce Rate0
Pageviews per Visit0
Avg. Visit Duration0
Estimated monthly visitsOctober 20250
November 20250
December 20250
Traffic sourcesSocial-
Paid Referrals-
Mail-
Referrals-
Search-
Direct-

About Equitymcapital

EquityMcapital is not authorised by the UK Financial Conduct Authority and may be providing financial services or products in the UK without permission, as stated in the FCA warning published on 21 October 2024. Clients would not be covered by the Financial Ombudsman Service or the Financial Services Compensation Scheme in such cases.

The Austrian Financial Market Authority (FMA) issued a warning on 13 November 2024 against EquityMCapital Ltd, citing that the firm is not authorised to conduct banking or securities trading services in Austria under the Banking Act.

The broker claims regulation by CySEC and ASIC, but no matching records have been found in either regulator's registry. The company is therefore considered unregulated. No evidence was found of segregated accounts, client protection schemes, or negative balance protection. Reported minimum deposit starts from €10,000, leverage up to 200:1, spreads around 2.0 pips on key currency pairs, and no withdrawal terms or platforms were officially confirmed.

Who it’s for

  • There is insufficient verified information to responsibly identify a specific target audience.

Pros and cons

Pros

  • No verifiable regulatory approvals; broker operates without established oversight.
  • High barriers to entry with minimum deposits starting from €10,000.
  • The FCA warning indicates a risk of unauthorised operations in the UK.
  • The FMA alert underscores lack of licensing in Austria.

Cons

  • No confirmed licences or protections (e.g., FSCS, ombudsman, client fund segregation).
  • Unverified trading conditions—spreads, leverage, and platform details remain unendorsed by trusted sources.
  • Regulatory notices explicitly advise against dealing with this firm.

Page loaded in 436.00 ms